Plante Moran Financial Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.1K | Buy |
+353
| New | +$19.2K | ﹤0.01% | 504 |
|
|
2026
Q1 | – | Sell |
-40
| Closed | -$3.81K | – | 744 |
|
|
2025
Q4 | $3.81K | Buy |
+40
| New | +$3.92K | ﹤0.01% | 667 |
|
|
2025
Q3 | – | Sell |
-578
| Closed | -$62.1K | – | 802 |
|
|
2025
Q2 | $62.1K | Sell |
578
-756
| -57% | -$76.5K | ﹤0.01% | 304 |
|
|
2025
Q1 | $135K | Buy |
+1,334
| New | +$134K | 0.01% | 206 |
|
|
2024
Q3 | – | Sell |
-53
| Closed | -$4.08K | – | 879 |
|
|
2024
Q2 | $4.08K | Buy |
+53
| New | +$3.88K | ﹤0.01% | 665 |
|
|
2024
Q1 | – | Sell |
-44
| Closed | -$2.54K | – | 856 |
|
|
2023
Q4 | $2.54K | Buy |
+44
| New | +$2.35K | ﹤0.01% | 704 |
|
|
2022
Q1 | – | Sell |
-337
| Closed | -$14K | – | 828 |
|
|
2021
Q4 | $14K | Buy |
+337
| New | +$14.2K | ﹤0.01% | 621 |
|
|
2021
Q2 | – | Sell |
-70
| Closed | -$3K | – | 959 |
|
|
2021
Q1 | $3K | Buy |
+70
| New | +$2.65K | ﹤0.01% | 845 |
|
|
2020
Q2 | – | Sell |
-224
| Closed | -$7K | – | 759 |
|
|
2020
Q1 | $7K | Buy |
224
+55
| +33% | +$2.15K | ﹤0.01% | 530 |
|
|
2019
Q4 | $8K | Sell |
169
-159
| -48% | -$6.65K | ﹤0.01% | 562 |
|
|
2019
Q3 | $13K | Buy |
+328
| New | +$13.9K | ﹤0.01% | 553 |
|
|
2019
Q1 | – | Sell |
-800
| Closed | -$28K | – | 785 |
|
|
2018
Q4 | $28K | Buy |
+800
| New | +$29K | 0.01% | 382 |
|
|
2018
Q2 | – | Sell |
-524
| Closed | -$14K | – | 829 |
|
|
2018
Q1 | $14K | Hold |
524
| – | – | 0.01% | 555 |
|
|
2017
Q4 | $13K | Hold |
524
| – | – | 0.01% | 554 |
|
|
2017
Q3 | $15K | Hold |
524
| – | – | 0.01% | 494 |
|
|
2017
Q2 | $15K | Sell |
524
-100
| -16% | -$2.65K | 0.01% | 504 |
|
|
2017
Q1 | $16K | Hold |
624
| – | – | 0.01% | 512 |
|
|
2016
Q4 | $13K | Sell |
624
-89
| -12% | -$1.94K | 0.01% | 542 |
|
|
2016
Q3 | $17K | Hold |
713
| – | – | 0.01% | 514 |
|
|
2016
Q2 | $17K | Buy |
713
+15
| +2% | +$325 | 0.01% | 452 |
|
|
2016
Q1 | $13K | Sell |
698
-402
| -37% | -$7.06K | 0.01% | 443 |
|
|
2015
Q4 | $20K | Buy |
1,100
+376
| +52% | +$6.74K | 0.02% | 447 |
|
|
2015
Q3 | $12K | Sell |
724
-121
| -14% | -$2.07K | 0.01% | 456 |
|
|
2015
Q2 | $15K | Hold |
845
| – | – | 0.01% | 457 |
|
|
2015
Q1 | $15K | Hold |
845
| – | – | 0.01% | 449 |
|
|
2014
Q4 | $11K | Hold |
845
| – | – | 0.01% | 515 |
|
|
2014
Q3 | $10K | Hold |
845
| – | – | 0.01% | 535 |
|
|
2014
Q2 | $11K | Buy |
+845
| New | +$11K | 0.01% | 496 |
|
|
2014
Q1 | – | Sell |
-750
| Closed | -$9K | – | 628 |
|
|
2013
Q4 | $9K | Buy |
+750
| New | +$8.86K | 0.01% | 465 |
|
Other funds holding BSX
Plante Moran Financial Advisors's BSX Position: Q2 2026 in Review
Plante Moran Financial Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 353 shares worth $15.1K. The stake represents ﹤0.01% of the portfolio and ranks #504 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in BSX as recently as Q4 2025.
Plante Moran Financial Advisors first reported a position in BSX in Q4 2013 and has held it in 29 quarters since. The position peaked at $135K in Q1 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Plante Moran Financial Advisors held 353 shares of Boston Scientific worth $15.1K as of Q2 2026.
- Boston Scientific was a new Plante Moran Financial Advisors position in Q2 2026.
- Boston Scientific made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #504 holding.
- Plante Moran Financial Advisors first reported a position in Boston Scientific in Q4 2013 and has held it in 29 quarters since.
- Plante Moran Financial Advisors's Boston Scientific position peaked at $135K in Q1 2025.
- 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.